James F. Hinrichs - 06 Jun 2022 Form 4 Insider Report for Orthofix Medical Inc. (OFIX)

Role
Director
Signature
/s/ Kimberley A. Elting, President, Global Orthopedics & Chief Legal and Development Officer, by power of attorney
Issuer symbol
OFIX
Transactions as of
06 Jun 2022
Transactions value $
$0
Form type
4
Filing time
08 Jun 2022, 16:32:59 UTC
Previous filing
01 Jun 2022
Next filing
21 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OFIX Common Stock Award $0 +6.38K +11.33% $0.00 62.7K 06 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vest in full on the first anniversary of the grant date, June 6, 2022.